Application of Mesenchymal Stem Cell Sheet to Treatment of Ischemic Heart Disease

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2021 Jul 8

PMID 34233729

Citations 22

Authors

Dehua Chang

Taibing Fan

Shuang Gao

Yongqiang Jin

Mingkui Zhang

Minoru Ono

Affiliations

Soon will be listed here.

Abstract

In recent years, mesenchymal stem cells (MSCs) have been used to improve cardiac function and attenuate adverse ventricular remodeling of the ischemic myocardium through paracrine effects and immunoregulation functions. In combination with cell sheet technology, MSCs could be more easily transplanted to the ischemic area. The long-term retention of MSCs in the affected area was realized and significantly improved the curative effect. In this review, we summarized the research and the applications of MSC sheets to the treatment of ischemic heart tissue. At present, many types of MSCs have been considered as multipotent cells in the treatment of heart failure, such as bone marrow-derived mesenchymal stem cells (BM-MSCs), adipose-derived mesenchymal stem cells (AD-MSCs), umbilical cord-derived mesenchymal stem cells (UC-MSCs), and skeletal myoblasts (SMs). Since UC-MSCs have few human leukocyte antigen-II and major histocompatibility complex class I molecules, and are easy to isolate and culture, UC-MSC sheets have been proposed as a candidate for clinical applications to ischemic heart disease.

Citing Articles

Preclinical Evaluation of the Safety, Toxicity and Efficacy of Genetically Modified Wharton's Jelly Mesenchymal Stem/Stromal Cells Expressing the Antimicrobial Peptide SE-33.

Gasanov V, Kashirskikh D, Khotina V, Kuzmina D, Nikitochkina S, Mukhina I Cells. 2025; 14(5).

PMID: 40072070 PMC: 11898551. DOI: 10.3390/cells14050341.

Umbilical cord-derived mesenchymal stromal cells: Promising therapy for heart failure.

Li Y, Chen E, Ren B World J Cardiol. 2025; 17(1):101153.

PMID: 39866217 PMC: 11755126. DOI: 10.4330/wjc.v17.i1.101153.

Current Advances and Future Directions of Pluripotent Stem Cells-Derived Engineered Heart Tissue for Treatment of Cardiovascular Diseases.

He X, Good A, Kalou W, Ahmad W, Dutta S, Chen S Cells. 2025; 13(24).

PMID: 39768189 PMC: 11674482. DOI: 10.3390/cells13242098.

Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescence.

Sun H, Zhai H, Han K, Ma H, Tan Y, Li S J Transl Med. 2024; 22(1):1039.

PMID: 39558365 PMC: 11575038. DOI: 10.1186/s12967-024-05814-3.

Control of myotube orientation using ultrasonication.

Hashiguchi R, Ichikawa H, Kumeta M, Koyama D Sci Rep. 2024; 14(1):25737.

PMID: 39468262 PMC: 11519932. DOI: 10.1038/s41598-024-77277-x.

References

Yang L, Soonpaa M, Adler E, Roepke T, Kattman S, Kennedy M . Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 2008; 453(7194):524-8. DOI: 10.1038/nature06894. View

Nakao M, Inanaga D, Nagase K, Kanazawa H . Characteristic differences of cell sheets composed of mesenchymal stem cells with different tissue origins. Regen Ther. 2019; 11:34-40. PMC: 6517796. DOI: 10.1016/j.reth.2019.01.002. View

Ishida O, Hagino I, Nagaya N, Shimizu T, Okano T, Sawa Y . Adipose-derived stem cell sheet transplantation therapy in a porcine model of chronic heart failure. Transl Res. 2015; 165(5):631-9. DOI: 10.1016/j.trsl.2014.12.005. View

Siltanen A, Kitabayashi K, Patila T, Ono M, Tikkanen I, Sawa Y . Bcl-2 improves myoblast sheet therapy in rat chronic heart failure. Tissue Eng Part A. 2010; 17(1-2):115-25. DOI: 10.1089/ten.TEA.2010.0205. View

Kawamura M, Miyagawa S, Fukushima S, Saito A, Miki K, Ito E . Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart. Circulation. 2013; 128(11 Suppl 1):S87-94. DOI: 10.1161/CIRCULATIONAHA.112.000366. View

Hamdi H, Planat-Benard V, Bel A, Puymirat E, Geha R, Pidial L . Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections. Cardiovasc Res. 2011; 91(3):483-91. DOI: 10.1093/cvr/cvr099. View

Muthna D, Soukup T, Vavrova J, Mokry J, Cmielova J, Visek B . Irradiation of adult human dental pulp stem cells provokes activation of p53, cell cycle arrest, and senescence but not apoptosis. Stem Cells Dev. 2010; 19(12):1855-62. DOI: 10.1089/scd.2009.0449. View

Amorin B, Alegretti A, Valim V, Pezzi A, Laureano A, Silva M . Mesenchymal stem cell therapy and acute graft-versus-host disease: a review. Hum Cell. 2014; 27(4):137-50. PMC: 4186969. DOI: 10.1007/s13577-014-0095-x. View

Thakker R, Yang P . Mesenchymal stem cell therapy for cardiac repair. Curr Treat Options Cardiovasc Med. 2014; 16(7):323. PMC: 4295923. DOI: 10.1007/s11936-014-0323-4. View

10.

Sawa Y, Miyagawa S, Sakaguchi T, Fujita T, Matsuyama A, Saito A . Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: report of a case. Surg Today. 2011; 42(2):181-4. DOI: 10.1007/s00595-011-0106-4. View

11.

Sawa Y, Yoshikawa Y, Toda K, Fukushima S, Yamazaki K, Ono M . Safety and Efficacy of Autologous Skeletal Myoblast Sheets (TCD-51073) for the Treatment of Severe Chronic Heart Failure Due to Ischemic Heart Disease. Circ J. 2015; 79(5):991-9. DOI: 10.1253/circj.CJ-15-0243. View

12.

Okura H, Matsuyama A, Lee C, Saga A, Kakuta-Yamamoto A, Nagao A . Cardiomyoblast-like cells differentiated from human adipose tissue-derived mesenchymal stem cells improve left ventricular dysfunction and survival in a rat myocardial infarction model. Tissue Eng Part C Methods. 2009; 16(3):417-25. DOI: 10.1089/ten.TEC.2009.0362. View

13.

Okano T, Yamada N, OKUHARA M, Sakai H, Sakurai Y . Mechanism of cell detachment from temperature-modulated, hydrophilic-hydrophobic polymer surfaces. Biomaterials. 1995; 16(4):297-303. DOI: 10.1016/0142-9612(95)93257-e. View

14.

Shi H, Liang M, Chen W, Sun X, Wang X, Li C . Human induced pluripotent stem cell‑derived mesenchymal stem cells alleviate atherosclerosis by modulating inflammatory responses. Mol Med Rep. 2017; 17(1):1461-1468. PMC: 5780084. DOI: 10.3892/mmr.2017.8075. View

15.

Kim K, Bou-Ghannam S, Thorp H, Grainger D, Okano T . Human mesenchymal stem cell sheets in xeno-free media for possible allogenic applications. Sci Rep. 2019; 9(1):14415. PMC: 6783458. DOI: 10.1038/s41598-019-50430-7. View

16.

Minieri V, Saviozzi S, Gambarotta G, Lo Iacono M, Accomasso L, Cibrario Rocchietti E . Persistent DNA damage-induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells. J Cell Mol Med. 2015; 19(4):734-43. PMC: 4395188. DOI: 10.1111/jcmm.12387. View

17.

Salehinejad P, Alitheen N, Ali A, Omar A, Mohit M, Janzamin E . Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly. In Vitro Cell Dev Biol Anim. 2012; 48(2):75-83. DOI: 10.1007/s11626-011-9480-x. View

18.

Kobayashi J, Kikuchi A, Aoyagi T, Okano T . Cell sheet tissue engineering: Cell sheet preparation, harvesting/manipulation, and transplantation. J Biomed Mater Res A. 2019; 107(5):955-967. DOI: 10.1002/jbm.a.36627. View

19.

Fukumori K, Akiyama Y, Kumashiro Y, Kobayashi J, Yamato M, Sakai K . Characterization of ultra-thin temperature-responsive polymer layer and its polymer thickness dependency on cell attachment/detachment properties. Macromol Biosci. 2010; 10(10):1117-29. DOI: 10.1002/mabi.201000043. View

20.

Horwitz E, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini F . Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005; 7(5):393-5. DOI: 10.1080/14653240500319234. View